The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Auvi-Q
Auvi-Q · EPINEPHRINE .1 mg/.1mL · Injection, Solution · Intramuscular · HF Acquisition Co LLC, DBA HealthFirst
NDC 51662-1661-02 · 2 DOSE PACK in 1 CARTON / .1 mL in 1 DOSE PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- HF Acquisition Co LLCUnited Statesrelabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $689.21 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA201739
- TE code
- BX
- Approval date
- Aug 10, 2012
- Patents / exclusivity
- 24 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 10688244 | Dec 21, 2037 |
| patent | 11771830 | Dec 21, 2037 |
| patent | 11771830 | Dec 21, 2037 |
| patent | 10842938 | Dec 21, 2037 |
| patent | 10688244 | Dec 21, 2037 |
| patent | 10842938 | Dec 21, 2037 |
| patent | 8021344 | Nov 2, 2029 |
| patent | 8021344 | Nov 2, 2029 |
| patent | 8021344 | Nov 2, 2029 |
| patent | 8226610 | Apr 10, 2029 |
| patent | 8226610 | Apr 10, 2029 |
| patent | 8226610 | Apr 10, 2029 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Auvi-Q (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | EPINEPHRINE .1 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | EPINEPHRINE .15 mg/.15mL | Jul 15, 2026 | Sep 2, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | EPINEPHRINE .3 mg/.3mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Auvi-Q — NDC 51662-1661-02," retrieved September 3, 2026, https://drugdashboards.com/drug/51662166102.
Free to cite with attribution — see how the data is put together.